Skip to main content

Pathology Grand Rounds - EGFR, Targeted Therapy and Resistance in Non-Small Cell Lung Carcinoma

October 1, 2021 - 12:00pm to 1:00pm
Weiwei Shi, MD, PhD

At the conclusion of this activity, learners should be able to:

* Understand the role of EGFR in lung cancer

* Know the discovery of EGFR mutations in NSCLC

* Recognize secondary and tertiary EGFR mutations

* Distinguish small cell transformation

* Introduce the pathology workflow for the EGFR-mutant NSCLC